In search of a new paradigm for protective immunity to TB
about
Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogensComplexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in TuberculosisThe re-emergency and persistence of vaccine preventable diseasesApplications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyVaccines for TB: Lessons from the Past Translating into Future PotentialsMR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosisDefining features of protective CD4 T cell responses to Mycobacterium tuberculosisImmunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during TreatmentComputational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome.Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of TuberculosisAntibodies and tuberculosisTuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosisTuberculosis vaccines: barriers and prospects on the quest for a transformative toolDissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional modelStrategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational StudyR&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014.What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan".The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.Novel vaccination approaches to prevent tuberculosis in childrenRisk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsCellular requirements for systemic control of Salmonella enterica serovar Typhimurium infections in mice.Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.Genetically diverse mice are novel and valuable models of age-associated susceptibility to Mycobacterium tuberculosis.Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosisHuman and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of TCR SelectionThe contribution of non-human primate models to the development of human vaccinesLong noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection.STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection.Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice.Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosisThe COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection.Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infectionHIV Disrupts Human T Cells That Target Mycobacterial GlycolipidsThe TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.HIV Progression Perturbs the Balance of the Cell-Mediated and Anti-Inflammatory Adaptive and Innate Mycobacterial Immune Response.Analysis of the immune response of human dendritic cells to Mycobacterium tuberculosis by quantitative proteomics.ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivoLoss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine.
P2860
Q26750912-AC3C4B6A-DCF1-4456-95BA-3C2E0599B35FQ26779956-ABA169CA-EAD0-4104-876A-46850571ECD4Q26796600-9D0AE320-BD80-46E3-9A03-2D63D4AC97D1Q26798372-06E6A633-1E7E-4586-8B24-13F0E2B14987Q26996673-6C883891-7690-4B35-A875-D9A6578AE8D7Q27016137-36E42D70-0A0B-4938-894F-FB90183BBD35Q27022371-01330D79-4A55-41F5-B7E7-73572E280196Q27306144-D8A30ED3-0992-4C96-9650-F0FF9F3C7839Q27316676-6CE17006-8A68-415A-956E-4AB684980C22Q27327288-325ECD86-6188-465C-AD6F-F7C425CC5F37Q28067735-FC3A98A6-4980-49E4-A1BF-3BFD5070A9FDQ28079851-35F7FF7D-1E91-4E2F-BDCB-7104D2785067Q28390218-BE3F4FC1-2A8A-4214-BEBE-4732C6CA919DQ28468572-E0F2F33D-7D18-4428-A6AC-8FCF23A6B1DBQ28603191-ADA1B990-0ABD-43A2-BD0C-033BB9946D2DQ30379192-76A246DA-47C7-4670-A0EA-26FE15DFBDADQ33679240-3EE78C34-2CA3-4766-AA27-3B8C9629AB4CQ33751671-714F906A-0C2E-4974-856F-EFB647B6636BQ33801426-E3C2303C-B2AF-4628-9383-2663CFC143ACQ33809045-58A862AC-18EE-4F4E-9F8C-AFDA65A38242Q34595652-00D4FA88-2EAC-428C-A33F-A310B7198DAEQ34603687-D725661B-A2E0-4CF0-85A2-6CA59C1EE8A6Q34790516-188DAD5F-3FDB-48A7-A955-3BE3B4F4068CQ34986125-3F17E227-28CE-4821-A852-917B7B18626CQ35039934-34BF759D-C395-4CAA-A9AC-2D4C1C8CEAE6Q35577267-803AF655-53C8-4CB7-89A9-DF35F9162038Q35737990-F41446A5-C8F9-4347-AE6F-147155A1A05FQ35895721-83A705BE-B3C1-4F5A-9EC6-375FBB8123F9Q35899422-E628DD42-8275-46EB-B854-8D33CEF9FE84Q36090847-2B055BB7-35FE-4A86-8D3C-70584C7187F7Q36169358-F772B0DF-E547-4C35-9DDB-88994F575C76Q36173327-5E748A9B-FE07-4B13-B250-F9C556A7C617Q36303844-474DD262-8F53-44D4-8636-495A7D73C4D8Q36338512-61464D2D-A816-4C34-AEFC-67E4712BE8FDQ36487871-4D7A3D3E-8E96-4E54-B99A-26CFED40B77FQ36636763-3F1CA22C-72ED-4BEA-82B4-3287A8390AD6Q36661362-2B2D38B9-6514-4037-A88A-F56C5A31BB5CQ36662464-F9DE0F3F-3A52-48B6-A276-CF749EC65D99Q36951826-F94D6E9B-1FA8-4B70-A958-2924A60307C2Q37054583-FCA6B83C-1014-4D88-A0F4-4189D0723A75
P2860
In search of a new paradigm for protective immunity to TB
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
In search of a new paradigm for protective immunity to TB
@en
type
label
In search of a new paradigm for protective immunity to TB
@en
prefLabel
In search of a new paradigm for protective immunity to TB
@en
P2860
P50
P356
P1476
In search of a new paradigm for protective immunity to TB
@en
P2093
Cláudio Nunes-Alves
Pushpa Jayaraman
P2860
P2888
P304
P356
10.1038/NRMICRO3230
P407
P577
2014-03-03T00:00:00Z
P5875
P6179
1006235999